Cencora, Inc.
Cencora, Inc., headquartered in the United States, is a prominent player in the global pharmaceutical and life sciences industry. Founded in 2022, the company has quickly established itself as a leader in providing comprehensive supply chain solutions, clinical trial services, and logistics for biopharmaceutical products. With a strong operational presence across North America, Europe, and Asia, Cencora is dedicated to enhancing patient access to innovative therapies. Cencora's unique offerings include temperature-controlled logistics and tailored distribution services, ensuring the integrity of sensitive products throughout the supply chain. The company’s commitment to quality and efficiency has earned it a notable position in the market, recognised for its ability to streamline processes and reduce time-to-market for critical medications. As Cencora continues to grow, it remains focused on delivering exceptional value to its partners and clients in the ever-evolving healthcare landscape.
DitchCarbon Score
How does Cencora, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cencora, Inc.'s score of 36 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cencora, Inc.'s reported carbon emissions
Cencora, Inc., headquartered in the United States, has set ambitious climate commitments despite not reporting specific carbon emissions data. The company aims to achieve net zero emissions by 2050, focusing on both Scope 1 and Scope 2 emissions. Cencora has committed to reducing absolute greenhouse gas emissions from its operations by 54.6% by FY2032, using FY2019 as the baseline year. Additionally, the company plans for 82% of its suppliers, based on spend, to have science-based targets by FY2027. These targets align with the necessary reductions to limit global warming to 1.5°C, demonstrating Cencora's commitment to sustainable practices within the healthcare sector. Overall, while specific emissions figures are not available, Cencora's long-term strategies reflect a proactive approach to addressing climate change and enhancing environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cencora, Inc. is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
